DIRS.INFO The most relevant business & tech news

Here's a rapid-fire update on all the stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. This time around, Trump's tariff proposals on Chinese imports could help Amazon in its competition against low-price online sellers Temu and Shein. Salesforce : Not a Trump stock, but it wasn't a Kamala Harris stock either. Constellation Brands : The Mexican beer importer has been punished on fears about what Trump's tariff and immigration proposals could do to its business. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Jim, Donald Trump's, Trump's, Abbott, Trump, Hock Tan, Tan, We'll, it's pricier, Morgan Stanley, Wells, Kamala Harris, Agentforce, That's, Biden, Dover, Eaton's, Elon, Waymo, JD Vance, we've, Linde, that's, Eli Lilly, Robert F, Kennedy Jr, Kennedy, Lilly, Mark Zuckerberg, Zuckerberg, Goldman Sachs, shouldn't, Nextracker, Brian Niccol, Niccol, Stanley Black, Decker, TJ Maxx, Wells Fargo, Jim Cramer Organizations: Jim Cramer's Charitable Trust, CNBC, Abbott Laboratories, Abbott Labs, White, Biden, AMD, Trump, Wednesday, Broadcom, VMWare, BlackRock, Costco, Coterra Energy, Coterra, DuPont, Disney, GE Healthcare, GE Aerospace, Google, Honeywell, Elliott Investment Management, Linde, Microsoft, Big Tech, Apple, Meta, Financial Times, Nvidia, Palo Alto Networks, Yum Brands, Taco Bell, Constellation Brands, Management, TJX, Marshalls, Jim Cramer's Charitable Locations: China, India, Missouri, Wells Fargo, BlackRock, Shanghai, Dover, U.S, Palo, HomeGoods

☆ Jim Cramer takes a closer looks at the litigation facing Abbott and what it means for the company
▼ + stars: | 2024-11-01 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJim Cramer takes a closer looks at the litigation facing Abbott and what it means for the company'Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs.

Persons: Jim Cramer, Abbott Organizations: Abbott Labs

☆ Jim Cramer: Abbott stock is 'dirt cheap' after a surprising legal win validates our conviction
▼ + stars: | 2024-11-01 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +5 min

The legal overhang on Abbott Labs has been real, even if shares have found some traction in recent months. Bottom line Abbott Labs still faces other cases over its specialized formulas across the country, but Thursday night's win is significant. Abbott shares traded around 22 times forward earnings estimates Friday, below their five-year average of 24, according to FactSet. With victory in hand, Abbott Labs will now begin the next phase of its legal fight on much stronger ground. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: Mead Johnson, Benckiser, Louis Children's, Abbott, Mead, —, Scott Stoffel, ABT, — Mead Johnson, Jim Cramer, Cramer, Jim Cramer's, Jim, Stacey Wescott Organizations: Abbott Laboratories, Club, Abbott Labs, NEC, CNBC, Abbott, and Drug Administration, Centers for Disease Control, National Institutes of Health, FDA, CDC, NIH, Chicago Tribune, Tribune, Service, Getty Locations: Missouri, St

☆ Jim Cramer's hopeful on Abbott Labs after court case win
▼ + stars: | 2024-11-01 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

But Thursday night, the jury from its second trial found the company not liable. The second trial was brought before the same judge in Missouri as the first one. Abbott Labs' shares jumped on Friday in response to the news, finishing the session up 4.61%. Cramer listed reasons he's positive on Abbott Labs, saying he likes the company's four core businesses, especially its medical device arm focused on cardiology and diabetes. Abbott Labs did not immediately respond to request for comment.

Persons: CNBC's Jim Cramer, Abbott's, necrotizing, Cramer, Health —, Abbott Organizations: Abbott Laboratories, NEC, Abbott Labs, and Drug Administration, Center for Disease Control, National Institutes, Health, Abbott Locations: Missouri

☆ The lawsuits against Abbott 'really steam me', says Jim Cramer
▼ + stars: | 2024-11-01 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe lawsuits against Abbott 'really steam me', says Jim Cramer'Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs.

Persons: Abbott, Jim Cramer Organizations: Abbott Labs

☆ Palo Alto shares helped by contract news, Abbott Labs braces for lawsuit ruling
▼ + stars: | 2024-10-31 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +6 min

An executive at Palo Alto Networks also posted about it on LinkedIn , without mentioning the dollar amount and duration. These headlines could be helping support shares of Palo Alto in Thursday's down market. Palo Alto did not respond to CNBC's request for comment on the licensing agreement. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, nonfarm, Morgan Stanley, Palo, Nikesh Arora, —, Missouri —, we're, Jeff Marks, Abbott, we'll, payrolls, Jim Cramer's, Jim Organizations: CNBC, ., Nasdaq, Dow Jones Industrial, Microsoft, Meta, Boeing, Reserve, Palo Alto Networks, Department of Defense, Palo, Abbott Labs, NEC, Judicial, Apple, Coterra Energy, Intel, . Steel, Juniper Networks, Chevron, Exxon Mobil, LyondellBasell, Jim Cramer's Charitable Locations: U.S, Palo Alto, Thursday's, Missouri

☆ Calls of the Day: Crowdstrike, Cheniere Energy, 3M, Abbott Labs, Abbvie and Eli Lilly
▼ + stars: | 2024-10-17 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCalls of the Day: Crowdstrike, Cheniere Energy, 3M, Abbott Labs, Abbvie and Eli LillyThe Investment Committee debate the latest Calls Of The Day.

Persons: Eli Lilly Organizations: Cheniere Energy, Abbott Labs

☆ Embattled Abbott Labs comes through with a strong quarter, buyback announcement
▼ + stars: | 2024-10-16 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +9 min

Organic sales, which exclude Covid testing, were up 8.2% from the year-ago period. Bottom line In its third quarter, Abbott Labs demonstrated why we wanted to stick with the stock in the face of legal battles that emerged earlier this year and spooked investors. "There's just a lot to like with the Abbott quarter." As Abbott's organic sales growth continues to shine, the market will realize both concerns are overblown. The company reiterated its full-year organic sales growth outlook of 9.5% to 10%.

Persons: ABT, Abbott, Jim Cramer, Dexcom, Robert Ford, Ford, Lingo, —, it's, Edwards, Jim Cramer's, Jim, Ethan Miller Organizations: Abbott Laboratories, Revenue, Abbott Labs, NEC, Abbott, Ford, and Drug Administration, Centers for Disease Control, National Institutes of Health, CNBC, Las Vegas Convention, Getty Locations: U.S, Missouri, Las Vegas , Nevada

☆ Cramer's Lightning Round: Sweetgreen is 'terrific'
▼ + stars: | 2024-10-16 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Oracle's year-to-date stock performance. Stock Chart Icon Stock chart icon AbbVie's year-to-date stock performance. Stock Chart Icon Stock chart icon Core Scientific's year-to-date stock performance. Stock Chart Icon Stock chart icon Clover Health's year-to-date stock performance. Stock Chart Icon Stock chart icon Sweetgreen's year-to-date stock performance.

Persons: Clover, Jim Cramer's Organizations: Abbott Labs, Clover Health, Logistics, GXO Logistics

☆ Committee Stocks on the Move: Interactive Brokers, Abbott Labs and Rio Tinto
▼ + stars: | 2024-10-16 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCommittee Stocks on the Move: Interactive Brokers, Abbott Labs and Rio TintoThe Investment Committee discuss some of their stocks on the move.

Organizations: Abbott Labs, Rio Tinto, Investment

☆ Here's an earnings homework checklist so you can be ready when your companies report
▼ + stars: | 2024-10-15 | by ( Zev Fima | ) www.cnbc.com time to read: +11 min

Wells Fargo on Friday was the first portfolio name to report third-quarter results, which have been greeted enthusiastically on Wall Street. Morgan Stanley and Abbott Laboratories — both Club names as well — report earnings before Wednesday's opening bell. Revenue and earnings estimates can be found on stock ticker pages on any number of free financial websites and through brokerage account providers. Portfolio management is a must. After considering these factors, be sure to then take a higher-level portfolio management view of your investments.

Persons: Wells, Morgan Stanley, Abbott Laboratories —, Jim Cramer's, —, Eli Lilly, writeups, Stanley Black, Decker, Jim, Jim Cramer, Andrew Kelly Organizations: Abbott Laboratories, Abbott Labs, Microsoft, TJX, Palo Alto Networks, Club, Nvidia, Devices, Taiwan Semiconductor Management Company, Jim Cramer's Charitable, CNBC, Flag, New York Stock Exchange Locations: Wells Fargo, U.S

☆ Earnings will drive the stock market in the week ahead. That's a good thing
▼ + stars: | 2024-10-13 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

In Friday's look at wholesale inflation, the producer price index was unchanged month over month . We'll hear from Club holdings Morgan Stanley and Abbott Laboratories on Wednesday morning. Morgan Stanley: The ongoing recovery in investment banking will be front and center. That was a key theme in the second quarter , and the hope is that the July-to-September period showed a continuation of the trend for Morgan Stanley. Morgan Stanley has been strong lately, though.

Persons: Jim Cramer, Jim, Gamble, — Wells, industrials, Goldman Sachs, ASML, Morgan Stanley, Morgan Stanley's, Louis, Abbott, Charles Schwab, Johnson, JB Hunt, Kinder Morgan, Huntington, Jim Cramer's, Charly Triballeau Organizations: Club, Dow Jones, Nasdaq, Procter, Federal, JPMorgan, —, Tech, . Utilities, UnitedHealth, Taiwan Semiconductor Manufacturing, Abbott Laboratories, Abbott Labs, NEC, Abbott, Food and Drug Administration, Walgreens Boots Alliance, Citigroup, Bank of America, United Airlines, Interactive, US Bancorp, Citizens, Alcoa, PPG Industries, CSX, Truist, Netflix, Crown Holdings, American Express, Gamble, CNBC, New York Stock Exchange, Financial, Afp, Getty Locations: Wells, U.S, Wells Fargo, St, Taiwan, New York City

☆ Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Microsoft, Wells Fargo, Disney, Apple, First Solar & more
▼ + stars: | 2024-10-08 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

"We reiterate our Overweight rating on the name as NVDA remains our Top Pick." JPMorgan reiterates Charles Schwab as overweight JPMorgan raised its price target on the stock to $86 per share from $78. "We are initiating coverage of Morningstar (MORN) with a Buy rating and a $390 price target. Wells Fargo reiterates Tesla as underweight Wells says it remains "skeptical" heading into Tesla's robotaxi day later this week. "We are initiating coverage of MBX Biosciences with an Overweight rating and Dec 2025 price target of $30."

Persons: Cantor Fitzgerald, Cantor, TD Cowen, Cowen, Wolfe, Wells, Bernstein, Oppenheimer, Goldman Sachs, Milton, Irma, JPMorgan, Charles Schwab, Morningstar, Redburn, Goldman, Tesla, TSLA, Key, Affirm's, it's, Morgan Stanley, it's bullish, Abbott, Susquehanna, KeyBanc Organizations: Anheuser Busch InBev, InBev, Humana, STARS, Microsoft, Disney, JPMorgan, UBS, Biotech, Legend Biotech, Barclays, Optimus, Qualcomm, Express, American Express, Netflix, Bicara Therapeutics, Abbott Labs, Howmet Aerospace, Commercial Aerospace & Defense, Bank of America, Apple, MBX Biosciences, Delta, Argus, McDonald's Corp Locations: China, Wells Fargo, F4Q17, 1H26, Tesla's

☆ Jim Cramer says Abbott Labs picked up a 'very big win' — here's where the stock is going
▼ + stars: | 2024-10-07 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Oil prices also continued their climb higher on escalating tensions in the Middle East — though Jim Cramer cautioned investors against chasing the concurrent rally in energy stocks at this point. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, downgrades, We'll, Morgan Stanley, Wells Fargo, Jim, Abbott, Louis, Stocks, Jim Cramer's Organizations: CNBC, Apple, DuPont, Constellation Brands, Federal, U.S, Bank, Abbott Laboratories, FDA, CDC, NIH, Abbott Labs, Pfizer, American Express, KB, Netflix, Air Products, Chemicals, Jim Cramer's Charitable Locations: U.S, St

☆ Cramer's Stop Trading: Abbott Labs
▼ + stars: | 2024-10-07 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer's Stop Trading: Abbott LabsCNBC’s Jim Cramer explains why he is keeping an eye on shares of Abbott Labs.

Persons: Jim Cramer Organizations: Abbott, Abbott Labs

☆ Move aside, AI: None of our top 5 stocks in the third quarter are in tech
▼ + stars: | 2024-09-27 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +8 min

The best-performing Club stocks during the topsy-turvy third quarter are all outside the "Magnificent Seven" and AI-winner complexes. Starbucks: 25.2% New CEO Brian Niccol is the reason why Starbucks' stock is on the list. Best Buy: 18.6% The electronics retailer is another rate-cut winner: More people moving means more purchases of appliances and TVs. In fact, the reasons to own Best Buy are underappreciated by investors, JPMorgan analysts said in a note to clients Friday. Like Stanley Black & Decker and Best Buy, Home Depot is a beneficiary of increased housing sector activity.

Persons: —, Stanley Black, Decker, Brian Niccol, Eli Lilly, Lilly, there's, Jim Cramer's, Jim Cramer, Jim, Donald Allan , Jr, Chris Taylor Organizations: Reserve, Starbucks, Deutsche Bank, GE Healthcare, Novo Nordisk, Abbott Laboratories, Abbott Labs, GE, JPMorgan, CNBC, The New York Stock Exchange, NYSE Global Locations: U.S, China

☆ Don't let Abbott Labs' litigation overhang keep you out of the stock
▼ + stars: | 2024-09-19 | by ( Paulina Likos | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Jim Cramer has been debating swapping Morgan Stanley for Goldman Sachs , which he argued is a "cheaper and better" bank option. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Morgan Stanley, Goldman Sachs, Jim, Lisa Su, Su, Piper Sandler, Abbott, Stocks, Jim Cramer's Organizations: CNBC, Federal Reserve, Nasdaq, Dow, Nvidia, Micro Devices, Micro, AMD's, Abbott Labs, Darden, AMD Locations: Turin

Here's a rapid-fire update on all 32 stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. AMD shares have caught a bid in recent days, but they're still cheap considering the growth of its AI processors. Broadcom : Investors who don't own any Broadcom yet should consider starting a position here, Jim said. Although it's tempting to offload shares, Jim said to stick with Honeywell for now because there's huge value in individual businesses like aerospace. There's little negative to say about this portfolio stock.

Persons: Jim Cramer's, Jim, Apple, haven't, it's, that's, he'll, Bob Iger, Bob Chapek, Larry Ellison, Biogen, Eli Lilly, Lowe's, Vimal Kapur, We'd, Linde, Lilly, Morgan Stanley, Goldman Sachs, It's, Jensen Huang, Kamala Harris, Republican Donald Trump, CrowdStrike, Palo, — we're, we're, Brian Niccol, Sands, Stanley Black, Decker, Wells, Charlie Scharf's, Jim Cramer, Angela Weiss Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Abbott Laboratories, Abbott Labs, AMD, Amazon, Web, Broadcom, VMWare, Federal Reserve, Costco Wholesale, Coterra, DuPont, New York Times, Oracle, GE Healthcare, GE, Honeywell, Linde, Microsoft, Nvidia, Republican, Palo Alto Networks, Palo, Procter & Gamble, Procter, Gamble, Constellation Brands, Modelo, Stanley, TJX, Marshalls, Jim Cramer's Charitable, Traders, New York Stock Exchange, AFP, Getty Locations: Nvidia's, San Francisco, China, Dover, United States, industrials, OpenAI, Palo Alto, Wells Fargo

☆ Here are Tuesday's biggest analyst calls: Nvidia, Apple, Roblox, Netflix, Amazon, Tesla, McDonald's, Affirm & more
▼ + stars: | 2024-07-30 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Loop initiates BrightView as buy Loop said it's bullish on shares of the commercial landscaping company. Evercore ISI reiterates Apple as outperform Evercore said it's bullish ahead of Apple earnings later this week. " Bank of America reiterates Roblox as buy Bank of America said it's standing by Roblox ahead of earnings on August 1. Deutsche Bank reiterates McDonald's as buy Deutsche said it's standing by the fast food giant following earnings. Bank of America reiterates Goldman Sachs as buy Bank of America said top pick Goldman Sachs has "cyclical/secular tailwinds."

Persons: Evercore, it's, Jensen Huang, Nvidia's Blackwell, Blackwell, KBW, Oppenheimer, Wells, Roblox, Tesla, McDonald's, Baird, Edward Jones, Goldman Sachs, ROE resiliency, Morgan Stanley, Wells Fargo Organizations: Apple, Citi, Nvidia, " Bank of America, of America, Barclays, UBS, Amazon, Netflix, Bank of America, JPMorgan, RBC, Tesla, Deutsche Bank, Deutsche, Whirlpool, underperform Bank of America, Abbott Laboratories, Abbott Labs, Edward, Stock, 2Q, PNC, WF

☆ Cramer’s Stop Trading: Abbott Labs
▼ + stars: | 2024-07-29 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCramer’s Stop Trading: Abbott LabsCNBC’s Jim Cramer explains why he is keeping an eye on shares of Abbott Laboratories.

Persons: Jim Cramer Organizations: Abbott, Abbott Laboratories

☆ 3-Stock Lunch: Abbott Labs, On Semiconductor and P&G
▼ + stars: | 2024-07-29 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email3-Stock Lunch: Abbott Labs, On Semiconductor and P&GWill McGough, Prime Capital Investment Advisors director of investments, joins 'Power Lunch' to discuss stock plays for three stocks.

Persons: Will McGough Organizations: Abbott Labs, Semiconductor, Prime Capital Investment

☆ Jim Cramer's advice on Abbott Labs stock after a nearly $500 million baby formula verdict
▼ + stars: | 2024-07-29 | by ( Matthew J. Belvedere | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Jim Cramer said Monday these are "going to be impactful situations." As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Thursday's, Jim, Abbott, Jim Cramer's Organizations: CNBC, Microsoft, Apple, Bloomberg, iPhone, Abbott Laboratories, Jim Cramer's Charitable

☆ Verdict against Abbott Labs is outrageous, says Jim Cramer
▼ + stars: | 2024-07-29 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

Verdict against Abbott Labs is outrageous, says Jim Cramer'Mad Money' host Jim Cramer shares his take on the Abbott Labs verdict.

Persons: Jim Cramer Organizations: Abbott Labs, Abbott

☆ An ugly earnings report from a competitor is good news for Abbott Labs
▼ + stars: | 2024-07-26 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. In the wreckage of Dexcom 's second-quarter earnings report, there's good news for Club holding Abbott Laboratories . As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Stocks, Stanley Black, Decker, Abbott, Dexcom, salesforce, Jim Cramer's, ABT, DOV, Jim Organizations: CNBC, Dow Jones, Nasdaq, Federal, U.S, Club, Abbott Laboratories, Dover, Mizuho Securities Locations: Dover

☆ Here's why Abbott Labs stock is getting dinged after a strong earnings beat
▼ + stars: | 2024-07-18 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

As Abbott's organic sales growth continues to shine, the market will realize both concerns are overblown. The FreeStyle Libre itself, which had 20% organic growth in the quarter, also still has plenty of runway for further growth. Investors should focus instead on the upward revision to management's full-year outlook for both top-line organic growth and earnings. The combination of Thursday's strong results and immediate decline in share price is setting up a positive risk vs. reward setup. Within Diagnostics, a small miss in molecular was more than offset by strong results in core laboratory, point of care and rapid diagnostics.

Persons: Abbott, Edwards, Robert Ford, It's, Jim Cramer's, ABT, Jim Cramer, Jim, Robert B, Ford, Ethan Miller Organizations: Abbott Labs, Abbott Laboratories, NEC, Rio, Libre, Management, Diagnostics, Devices, CNBC, Getty Locations: Missouri, Rio —, United States, U.S, Vegas, Las Vegas , Nevada

Search resuls for: "Abbott Labs"

25 mentions found